Sex-Mediated Differences in LPS Induced Alterations of TNFα, IL-10 Expression, and Prostaglandin Synthesis in Primary Astrocytes. 2018

Dmitry V Chistyakov, and Nadezda V Azbukina, and Alina A Astakhova, and Sergei V Goriainov, and Viktor V Chistyakov, and Marina G Sergeeva
Belozersky Institute of Physico-Chemical Biology, Moscow State University, Moscow 119992, Russia. chistyakof@gmail.com.

Although many neurological and psychiatric disorders reveal clear sex-dependent variations, the molecular mechanism of this process is not clear enough. Astrocytes are involved in the response of neural tissue to injury and inflammation, produce steroid hormones, and sense steroid presence. To explore the hypothesis that astrocytes may participate in sex-mediated differences of inflammatory responses, we have examined whether male and female primary rat astrocytes show different responses to lipopolysaccharide (LPS) as a toll-like receptor 4 (TLR4) agonist. Levels of mRNA and proteins of tumor necrosis factor alpha (TNFα), interleukin-10 (IL-10), and cyclooxygenase (COX)-2 were assessed using qPCR, immunoblotting, and ELISA. UPLC-MS/MS was used to detect prostaglandins (PGs). LPS stimulation resulted in different levels of cytokine production; more TNFα and less IL-10 were produced in female cells compared with male astrocytes. Although the levels of the COX-2 expression were not altered, LPS significantly induced the synthesis of PGs with notable sex-related differences. PGE₂ and PGD₂ were less and 6-keto-PGF1α was more upregulated in female astrocytes, and TXB₂ had similar levels in cells obtained from males and females. Trilostane, an inhibitor of 3β-Hydroxysteroid dehydrogenase (3β-HSD), inhibited the LPS-induced TNFα production and the release of PGE₂, PGD₂, and 6-keto-PGF1α in female astrocytes. Thus, male and female astrocytes differentially respond to inflammatory challenges on the level of production of cytokines and steroid hormones. Sex-mediated differences in pro- and anti-inflammatory responses should be taken into consideration for the effective treatment of disorders with neuroinflammation.

UI MeSH Term Description Entries
D007249 Inflammation A pathological process characterized by injury or destruction of tissues caused by a variety of cytologic and chemical reactions. It is usually manifested by typical signs of pain, heat, redness, swelling, and loss of function. Innate Inflammatory Response,Inflammations,Inflammatory Response, Innate,Innate Inflammatory Responses
D008070 Lipopolysaccharides Lipid-containing polysaccharides which are endotoxins and important group-specific antigens. They are often derived from the cell wall of gram-negative bacteria and induce immunoglobulin secretion. The lipopolysaccharide molecule consists of three parts: LIPID A, core polysaccharide, and O-specific chains (O ANTIGENS). When derived from Escherichia coli, lipopolysaccharides serve as polyclonal B-cell mitogens commonly used in laboratory immunology. (From Dorland, 28th ed) Lipopolysaccharide,Lipoglycans
D008297 Male Males
D011453 Prostaglandins A group of compounds derived from unsaturated 20-carbon fatty acids, primarily arachidonic acid, via the cyclooxygenase pathway. They are extremely potent mediators of a diverse group of physiological processes. Prostaglandin,Prostanoid,Prostanoids
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D005260 Female Females
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001253 Astrocytes A class of large neuroglial (macroglial) cells in the central nervous system - the largest and most numerous neuroglial cells in the brain and spinal cord. Astrocytes (from "star" cells) are irregularly shaped with many long processes, including those with "end feet" which form the glial (limiting) membrane and directly and indirectly contribute to the BLOOD-BRAIN BARRIER. They regulate the extracellular ionic and chemical environment, and "reactive astrocytes" (along with MICROGLIA) respond to injury. Astroglia,Astroglia Cells,Astroglial Cells,Astrocyte,Astroglia Cell,Astroglial Cell,Astroglias,Cell, Astroglia,Cell, Astroglial
D012333 RNA, Messenger RNA sequences that serve as templates for protein synthesis. Bacterial mRNAs are generally primary transcripts in that they do not require post-transcriptional processing. Eukaryotic mRNA is synthesized in the nucleus and must be exported to the cytoplasm for translation. Most eukaryotic mRNAs have a sequence of polyadenylic acid at the 3' end, referred to as the poly(A) tail. The function of this tail is not known for certain, but it may play a role in the export of mature mRNA from the nucleus as well as in helping stabilize some mRNA molecules by retarding their degradation in the cytoplasm. Messenger RNA,Messenger RNA, Polyadenylated,Poly(A) Tail,Poly(A)+ RNA,Poly(A)+ mRNA,RNA, Messenger, Polyadenylated,RNA, Polyadenylated,mRNA,mRNA, Non-Polyadenylated,mRNA, Polyadenylated,Non-Polyadenylated mRNA,Poly(A) RNA,Polyadenylated mRNA,Non Polyadenylated mRNA,Polyadenylated Messenger RNA,Polyadenylated RNA,RNA, Polyadenylated Messenger,mRNA, Non Polyadenylated
D012737 Sex Factors Maleness or femaleness as a constituent element or influence contributing to the production of a result. It may be applicable to the cause or effect of a circumstance. It is used with human or animal concepts but should be differentiated from SEX CHARACTERISTICS, anatomical or physiological manifestations of sex, and from SEX DISTRIBUTION, the number of males and females in given circumstances. Factor, Sex,Factors, Sex,Sex Factor

Related Publications

Dmitry V Chistyakov, and Nadezda V Azbukina, and Alina A Astakhova, and Sergei V Goriainov, and Viktor V Chistyakov, and Marina G Sergeeva
January 1998, International journal of immunopharmacology,
Dmitry V Chistyakov, and Nadezda V Azbukina, and Alina A Astakhova, and Sergei V Goriainov, and Viktor V Chistyakov, and Marina G Sergeeva
November 2025, Cells,
Dmitry V Chistyakov, and Nadezda V Azbukina, and Alina A Astakhova, and Sergei V Goriainov, and Viktor V Chistyakov, and Marina G Sergeeva
December 1990, Prostaglandins, leukotrienes, and essential fatty acids,
Dmitry V Chistyakov, and Nadezda V Azbukina, and Alina A Astakhova, and Sergei V Goriainov, and Viktor V Chistyakov, and Marina G Sergeeva
July 2013, Placenta,
Dmitry V Chistyakov, and Nadezda V Azbukina, and Alina A Astakhova, and Sergei V Goriainov, and Viktor V Chistyakov, and Marina G Sergeeva
April 2015, International immunopharmacology,
Dmitry V Chistyakov, and Nadezda V Azbukina, and Alina A Astakhova, and Sergei V Goriainov, and Viktor V Chistyakov, and Marina G Sergeeva
September 2004, Journal of leukocyte biology,
Dmitry V Chistyakov, and Nadezda V Azbukina, and Alina A Astakhova, and Sergei V Goriainov, and Viktor V Chistyakov, and Marina G Sergeeva
January 2011, PloS one,
Dmitry V Chistyakov, and Nadezda V Azbukina, and Alina A Astakhova, and Sergei V Goriainov, and Viktor V Chistyakov, and Marina G Sergeeva
January 2018, Frontiers in cellular neuroscience,
Dmitry V Chistyakov, and Nadezda V Azbukina, and Alina A Astakhova, and Sergei V Goriainov, and Viktor V Chistyakov, and Marina G Sergeeva
July 1998, British journal of haematology,
Dmitry V Chistyakov, and Nadezda V Azbukina, and Alina A Astakhova, and Sergei V Goriainov, and Viktor V Chistyakov, and Marina G Sergeeva
January 2019, Frontiers in physiology,
Copied contents to your clipboard!